Abstract:The traditional consensus that matrix metalloproteinases (MMPs) has correlation with various pathological and physiological processes led to the exploitation of a vast number of natural or synthetic broad-spectrum MMP inhibitors (MMPIs) for the prophylaxis or treatment of various MMP-related disorders, such as autoimmune, inflammatory, cardiovascular, neurodegenerative, respiratory diseases, and malignant cancer as well. Yet the unsatisfactory preclinical and/or clinical results motivated further investigation of the physiological roles of certain MMP subtypes. Despite the intricate and complicated MMP functions in normal physiology and disease pathology, the effort of designing specific inhibitors that can selectively target certain MMP family members for individualized therapy is ongoing and remains an arduous task. Success will rely on continued insight into the biological roles of these multifaced proteases. In our previous effort, we summarized various MMPIs that have entered preclinical or clinical trials as well as the patents in regard to MMPIs (Recent Pat Anticancer Drug Discov. 2010; 5(2): 109-41). In our on-going review, to illustrate the major challenges in MMP validation as druggable targets, we highlighted the physiological and pathological roles of representative MMPs, with an emphasis on description of the newly emerging MMPI-based patents, in particular, the inhibitors containing sulfonamide or sulfone motif. By analyzing the structural characteristics and selectivity profiles of these supplementary inhibitors, we hereby described their pharmaceutical application, and also expanded the strategies for potent MMPI design.

Matrix Metalloproteinase Inhibitors As Therapy for Inflammatory and Vascular Diseases.

Progress in Development of Matrix Metalloproteinase Inhibitors

Novel Drug Discovery Approaches for MMP-13 Inhibitors in the Treatment of Osteoarthritis

Recent Developments in Patent Anti-Cancer Agents Targeting the Matrix Metalloproteinases (Mmps)

Matrix Metalloproteinases As Novel Biomarker S and Potential Therapeutic Targets in Human Cancer

Matrix Metalloproteinases: New Targets in Cancer Therapy

Advances in Clinical Research of Matrix Metalloproteinase Inhibitors as Anticancer Agents

Matrix metalloproteinases involvement in pathologic conditions

Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics

Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling

Matrix Metalloproteinase Inhibitors (mmpis) As Attractive Therapeutic Targets: Recent Progress and Current Challenges

An Updated Patent Therapeutic Agents Targeting Mmps

Structure-based molecular insights into matrix metalloproteinase inhibitors in cancer treatments

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases

Matrix Metalloproteinases Inhibitors in Idiopathic Pulmonary Fibrosis: Medicinal Chemistry Perspectives

Matrix metalloproteases: variations on a theme

Phosphorus based inhibitors of matrix metalloproteinases

Targeting Matrix Metalloproteinases in Acute Inflammatory Shock Syndromes

Advances in Matrix Metalloproteinase Inhibitors Based on Pyrrolidine Scaffold

Epigenetic Regulation of Matrix Metalloproteinases in Inflammatory Diseases: a Narrative Review

Matrix Metalloproteinases in Tumorigenesis: an Evolving Paradigm